Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance

Global pandemics interconnected — obesity, impaired metabolic health and COVID-19

(2021) Norbert Stefan et al.   Nature Reviews Endocrinology

Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes

(2021) Sebastian Hörber et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Nonalcoholic fatty liver disease- evidence for a thrombophilic state?

(2020) Margaret Spinosa et al.   CURRENT PHARMACEUTICAL DESIGN

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

COVID-19 and its implications for thrombosis and anticoagulation

(2020) Jean Marie Connors et al.   BLOOD

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

(2020) Giovanni Targher et al.   GUT

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Causes, consequences, and treatment of metabolically unhealthy fat distribution

(2020) Norbert Stefan   Lancet Diabetes & Endocrinology

The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany

(2020) Antonia Petersen et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Endothelial Cell Contributions to COVID-19

(2020) Alexandra E. Oxford et al.   Pathogens

Visceral fat is associated to the severity of COVID-19

(2020) Guillaume Favre et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

(2019) Ian J Neeland et al.   Lancet Diabetes & Endocrinology

Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin

(2018) Gersina Rega-Kaun et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

C-reactive protein, obesity, and the risk of arterial and venous thrombosis

(2016) L. D. Horvei et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Adipose tissue location and contribution to postinjury hypercoagulability

(2016) Robert D. Winfield et al.   Journal of Trauma and Acute Care Surgery

Non-alcoholic fatty liver disease and risk of cardiovascular disease

(2016) Amedeo Lonardo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adipose tissue location and contribution to postinjury hypercoagulability

(2016) Robert D. Winfield et al.   Journal of Trauma and Acute Care Surgery

Phenotypes of prediabetes and stratification of cardiometabolic risk

(2016) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Procoagulant imbalance in patients with non-alcoholic fatty liver disease

(2014) Armando Tripodi et al.   JOURNAL OF HEPATOLOGY

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

(2014) Julia Kozlitina et al.   NATURE GENETICS

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2013) An Verrijken et al.   HEPATOLOGY

Ectopic fat: the true culprit linking obesity and cardiovascular disease?

(2013) Mariangela Morelli et al.   THROMBOSIS AND HAEMOSTASIS

Thrombosis in central obesity and metabolic syndrome: Mechanisms and epidemiology

(2013) Pierre-Emmanuel Morange et al.   THROMBOSIS AND HAEMOSTASIS

Topography mapping of whole body adipose tissue using A fully automated and standardized procedure

(2010) Christian Würslin et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease

(2010) Anna Kotronen et al.   LIVER INTERNATIONAL

Disorders of Coagulation and Hemostasis in Abdominal Obesity: Emerging Role of Fatty Liver

(2010) Giovanni Targher et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease

(2009) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS

Activated protein C levels in obesity and weight loss influence

(2008) Eva Solá et al.   THROMBOSIS RESEARCH